The association between albumin levels and survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis
Background: The albumin levels may potentially be used as a prognostic biomarker in patients with cancertreated with immune checkpoint inhibitors (ICIs) due to its close relationship with nutritional and inflammatory status. However, the available data is limited with heterogeneous patient cohorts,...
Main Authors: | Deniz Can Guven, Taha Koray Sahin, Enes Erul, Alessandro Rizzo, Angela Dalia Ricci, Sercan Aksoy, Suayib Yalcin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2022.1039121/full |
Similar Items
-
The Use of Phytochemicals to Improve the Efficacy of Immune Checkpoint Inhibitors: Opportunities and Challenges
by: Deniz Can Guven, et al.
Published: (2022-10-01) -
Targeting tumor microenvironment for cholangiocarcinoma: Opportunities for precision medicine
by: Riccardo Carloni, et al.
Published: (2022-11-01) -
Pretreatment albumin is a prognostic and predictive biomarker for response to atezolizumab across solid tumors
by: Jonas Saal, et al.
Published: (2023-01-01) -
The Role of Ischemia-modified Albumin and Ischemia-modified Albumin to Albumin Ratios in Patients with Alopecia Areata
by: Efsun TanaCan, et al.
Published: (2023-01-01) -
Mean Platelet Volume to Lymphocyte Ratio: A New Biomarker Predicting Response in Patients with Solid Tumors Treated with Nivolumab
by: Hasan Cagri Yildirim, et al.
Published: (2023-11-01)